Clinical Use of Apolipoprotein Quantitation

  1. Farooq A. Padder, MD;
  2. Puneet Sahgal, MD; and
  3. Ernesto E. Jonas, MD
  1. Nassau County Medical Center; East Meadow, NY 11554

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    In their excellent review article, Rader and colleagues [1] stated that a 10% decrease in apo B was associated with a 22% increase in coronary artery disease mortality. This result would appear contrary to the expected correlation derived from primary prevention trials such as those of the Lipid Research Clinics [2, 3]. How can this finding be explained?

    Farooq A. Padder, MD

    Puneet Sahgal, MD

    Ernesto E. Jonas, MD

    Nassau County Medical Center; East Meadow, NY 11554

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    References

    1. 1.
    2. 2.
    3. 3.
    « Previous | Next Article »Table of Contents

    Navigate This Article